Using AML cell lines would help to further elucidate mechanisms of secondary mutations in FLT3 and signaling cascades, but the utility of cell lines in studying the effects of the bone marrow stroma would be limited. The gene discussed is FLT3; the disease is acute myeloid leukemia.